Cinctive Capital Management’s 10x Genomics TXG Stock Holding History

Cinctive Capital Management’s Portfolio TXG Stock Details TXG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$922K	Buy	+24,057	New	+$630K	0.03%	329
2026 Q1	–	Sell	-34,019	Closed	-$555K	–	511
2025 Q4	$555K	Sell	34,019 -10,084	-23%	-$152K	0.03%	326
2025 Q3	$516K	Buy	+44,103	New	+$575K	0.02%	344
2025 Q1	–	Sell	-24,479	Closed	-$352K	–	466
2024 Q4	$352K	Sell	24,479 -138,106	-85%	-$2.18M	0.02%	329
2024 Q3	$3.67M	Buy	+162,585	New	+$3.36M	0.2%	168
2024 Q2	–	Sell	-13,234	Closed	-$497K	–	528
2024 Q1	$497K	Sell	13,234 -77,286	-85%	-$3.4M	0.02%	343
2023 Q4	$5.07M	Buy	+90,520	New	+$3.94M	0.34%	103
2023 Q3	–	Sell	-71,948	Closed	-$4.02M	–	493
2023 Q2	$4.02M	Sell	71,948 -81,778	-53%	-$4.43M	0.13%	218
2023 Q1	$8.58M	Buy	+153,726	New	+$7.18M	0.29%	116
2022 Q4	–	Sell	-18,788	Closed	-$535K	–	536
2022 Q3	$535K	Sell	18,788 -23,267	-55%	-$886K	0.02%	384
2022 Q2	$1.9M	Buy	+42,055	New	+$2.18M	0.08%	316
2021 Q2	–	Sell	-12,471	Closed	-$2.26M	–	611
2021 Q1	$2.26M	Buy	+12,471	New	+$2.15M	0.14%	249

Other funds holding TXG

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

QCM

Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Cinctive Capital Management's TXG Position: Q2 2026 in Review

Cinctive Capital Management opened a new position in 10x Genomics (TXG) in Q2 2026: 24,057 shares worth $922K. The stake represents 0.03% of the portfolio and ranks #329 among its holdings. This is a return to the name: Cinctive Capital Management previously reported a position in TXG as recently as Q4 2025.

Cinctive Capital Management first reported a position in TXG in Q1 2021 and has held it in 12 quarters since. The position peaked at $8.58M in Q1 2023. 391 funds tracked by Wall St. Rank hold TXG as of Q2 2026.

Cinctive Capital Management held 24,057 shares of 10x Genomics worth $922K as of Q2 2026.
10x Genomics was a new Cinctive Capital Management position in Q2 2026.
10x Genomics made up 0.03% of Cinctive Capital Management's portfolio in Q2 2026, its #329 holding.
Cinctive Capital Management first reported a position in 10x Genomics in Q1 2021 and has held it in 12 quarters since.
Cinctive Capital Management's 10x Genomics position peaked at $8.58M in Q1 2023.
391 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.

Based on Cinctive Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.